Skip to main content
Log in

Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses

  • Infectious Diseases
  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Kawasaki disease (KD) is an acute febrile illness of early childhood. Although the epidemiology of KD suggests an infectious agent, the cause still remains unknown. Intense immune activation during the acute disease has been well documented. Quantitative determination of soluble CD23 in serum can serve as an index of macrophage/monocyte or B-cell activation. To further characterize the immunological profile in KD, we investigated whether soluble CD23 levels in serum increase during the acute disease. In addition, we compared soluble CD23 levels in 33 patients with acute KD with levels in ten patients each with measles, rubella, infectious mononucleosis, and scarlet fever to determine if marked elevations in soluble CD23 were unique to acute KD. Patients with KD, rubella and infectious mononucleosis, but not patients with measles or scarlet fever, had increased soluble CD23 levels in serum during the acute stage, as compared to age-matched control subjects (P<0.01). These data suggest infection with Epstein-Barr virus and rubella and acute KD are all characterized by B-cell and macrophage/monocyte activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CAL :

coronary-artery lesions

IM :

infectious mononucleosis

KD :

Kawasaki disease

MAb :

monoclonal antibodies

References

  1. Abe J, Kozin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM (1992) Selective expansion of T-cells expressing T-cell receptor variable lesions Vß2 and Vß8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066–4070

    PubMed  Google Scholar 

  2. Al-Janadi M, Al-Wabel A, Raziuddin S (1994) Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin Immunol Immunopathol 71:33–37

    Article  PubMed  Google Scholar 

  3. Bansal AS, Pumphrey RS, Mandal BK, Khoo SH, Wilson PB (1990) Serum measurements of soluble CD23 in HIV infection. Immunology 80:652–653

    Google Scholar 

  4. Bansal AS, Robert T, Hay EM, Kay R, Pumphrey RSH, Wilson PB (1992) Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus. Clin Exp Immunol 89:452–455

    PubMed  Google Scholar 

  5. Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149–191

    PubMed  Google Scholar 

  6. Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, Yabuta K (1990) Expression of FcεR2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol 56:280–286

    Article  PubMed  Google Scholar 

  7. Furukawa S, Matsubara T, Motohashi T, Sasai K, Nakachi S, Umezawa Y, Yabuta K (1991) Increased expression of FcεR2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Int Arch Allergy Appl Immunol 95:7–12

    PubMed  Google Scholar 

  8. Furukawa S, Motohashi T, Matsubara T, Watanabe T, Obara T, Yabuta K (1992) Increased expression of CD23 on peripheral blood B cells and macrophages/monocytes during acute infectious mononucleosis. J Infect Dis 166:691–692

    PubMed  Google Scholar 

  9. Furukawa S, Matsubara T, Yabuta K (1992) Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child 67:706–708

    PubMed  Google Scholar 

  10. Furukawa S, Matsubara T, Okumura K, Yabuta K (1993) Decreased expression of CD23 on peripheral blood macrophages/monocytes during acute Kawasaki disease with coronary artery lesions. Int Arch Allergy Immunol 102:335–339

    PubMed  Google Scholar 

  11. Genot E, Sarfati M, Sigaux F, Petit-Kpskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, and Kolb J-P (1989) Effect of interferon-α on the expression and release of the CD23 molecule in Hairy cell leukemia. Blood 74:2455–2463

    PubMed  Google Scholar 

  12. Gordon J (1991) CD23: novel disease marker with a split personality. Clin Exp Immunol 86:356–359

    PubMed  Google Scholar 

  13. Kawasaki T, Kosaki G, Osawa S, Shigematsu I, Yanagawa S (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276

    PubMed  Google Scholar 

  14. Kicza K, Fischer A, Pfeil T, Bujanowski-Weber J, Konig W (1989) Cell-cell interaction for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors. Immunology 68:532–539

    PubMed  Google Scholar 

  15. Kikutani H, Suemura M, Owaki H, Nakamura H, Sato R, Yamasaki K, Barsumian EL, Hardy RR, Kishimoto T (1986) FcεR receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med 164:1455–1469

    Article  PubMed  Google Scholar 

  16. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM (1994) Toxic shock syndrome toxin-secreting staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385–1388

    Article  Google Scholar 

  17. Matsumoto T, Miike T, Yamaguchi K, Murakami M, Kawabe T, Yodoi J (1991) Serum levels of IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 85:288–292

    PubMed  Google Scholar 

  18. Melish ME, Parsonett J, Marchette N (1994) Kawasaki syndrome (KS) is not caused by toxic shock syndrome toxin-1 (TSST-1)+staphylococci (abstract). Pediatr Res 35:187A

    Google Scholar 

  19. Nadler LM (1986) B cell/leukemia panel workshops: Summary and comments? In: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds) Leukocyte typing II. Springer Verlag, Berlin Heidelberg New York, pp 4–43

    Google Scholar 

  20. Pietra BA, Inocencio JD, Giannini EH, Hirsch R (1994) TCR Vß family repertoire and T cell activation markers in Kawasaki disease. J Immunol 153:1881–1888

    PubMed  Google Scholar 

  21. Research Committee on Kawasaki Disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, pp 56–66

    Google Scholar 

  22. Sarfati M, Nutman T, Fonteyn C, Delespesse G (1986) Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors. Immunology 59:569–575

    PubMed  Google Scholar 

  23. Sarfati M, Lagneaux L, Fonteyn C, Frost H, Delespesse (1988) Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 71:94–98

    PubMed  Google Scholar 

  24. Vercelli D, Jabara HH, Lee B-W, Woodland N, Geha RS, Leung DYM (1988) Human recombinant interleukin 4 induces FcεR2/CD23 on normal human monocytes. J Exp Med 167: 1406–1416

    Article  PubMed  Google Scholar 

  25. Yanagawa H, Nakamura Y, Yashiro M, Fujita Y, Nagai M, Kawasaki T, Aso S, Imada Y, Shigematsu I (1988) A nationwide incidence survey of Kawasaki disease in 1985–1986 in Japan. J Infect Dis 158:1296–1301

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsubara, T., Furukawa, S., Motohashi, T. et al. Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses. Eur J Pediatr 154, 826–829 (1995). https://doi.org/10.1007/BF01959791

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01959791

Key words

Navigation